OneRay delivers robust, industry-specific solutions built around the most relevant use cases in life sciences. Our expanding ecosystem of intelligent agents is specifically designed to enhance knowledge work across pharmaceutical research, clinical development, regulatory affairs, and scientific operations. These advanced generative AI agents continuously evolve and adapt, showcasing multi-faceted capabilities that address your complex business challenges—from accelerating medical and regulatory processes to optimizing content generation and training. By focusing on real-world applications that matter most to life sciences professionals, OneRay empowers organizations to transform their knowledge work and drive meaningful innovation in healthcare advancement.
AI generated Regulatory Insights
Challenge: Time-consuming manual processing and error-prone labeling of vast regulatory data.
Solution: FFI-Ventures’ gen AI solution OneRay.ai integrates with Veeva’s RIM to automatically process and analyze regulatory documents. The system can:
This AI-driven approach significantly reduces the time and resources needed for regulatory intelligence, while improving accuracy and comprehensiveness.
AI Protocol & Clinical Study Report (CSR) Writing
Challenge: Tedious protocol and CSR writing, requiring extensive manual effort for alignment and data incorporation.
Solution: FFI-Ventures gen AI solution OneRay.ai, integrated with Veeva’s clinical data management platform, revolutionizes the protocol and CSR writing process:
This approach not only saves time but also improves the quality and consistency of these critical documents.
Content generation for healthcare professionals and patients
Challenge: Creating high-quality, channel-optimized content across multiple touchpoints while maintaining consistent messaging, appropriate tonality, and regulatory compliance—all within tight timelines that often bottleneck marketing and medical affairs teams.
Solution: By integrating OneRay.AI’s advanced content generation capabilities with your existing content management systems (e.g. Veeva Vault solutions), we deliver a comprehensive content optimization platform:
This intelligent content generation approach transforms content creation from a time-consuming task into a streamlined, scalable process that enhances communication effectiveness while ensuring regulatory integrity and accelerating time-to-market for critical materials.
Challenge: Medical, Legal, and Regulatory (MLR) review processes are often resource intense, with manual reviews consuming weeks of expert time while increasing risk of inconsistent feedback and delayed market access for critical materials.
Solution: By seamlessly integrating OneRay.AI’s intelligent review capabilities directly into your Veeva environment, OneRay.AI offers an automated LMR review system that accellerates approval workflows:
This integrated approach reduces LMR review cycles from weeks to days while improving review consistency and quality, enabling faster content approval and accelerated time-to-market for pharmaceutical communications and regulatory submissions.
AI guided Personalized Training & Medical Education
Challenge: Creating tailored training and educational materials for internal medical or commercial functions as well as healthcare professionals (HCPs) based on their specific needs, interests, and knowledge gaps.
Solution: By leveraging Veeva’s extensive Veeva Vault / Promomats data and FFI-Ventures’ generative AI solution OneRay, we create a personalized training and education platform:
This personalized approach enhances the effectiveness of medical education initiatives, ultimately improving patient care through better-informed healthcare providers.
Discover how our specialized AI solutions can transform your life sciences operations. Schedule a personalized demonstration where we’ll showcase relevant use cases specific to your organization’s challenges and objectives.
Our experts will walk you through practical applications tailored to your workflow, demonstrating how OneRay accelerates your research, streamline processes, and enhance decision-making across your organization.
As life sciences organizations allocate H2 2025 and 2026 budgets, the question isn't whether to invest in generative AI - it's how to implement it strategically for maximum impact.The...